Alpha Healthcare Acquisition Corp. (AHAC) to Combine with Humacyte in $849Mn Deal
Alpha Healthcare Acquisition Corp. (“AHAC”) announced this morning that it had entered into a definitive agreement to combine with biotech company Humacyte, Inc. (“Humacyte”) at an enterprise value of $849 million. Durham N.C. based Humacyte is a a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. The combined company isRead More